Skip to the content
FSHD Europe

FSHD Europe

FSHD

  • Home
  • About Us
    • Member Organisations
    • Contact
    • Who we are…
      • Sheila Hawkins
      • Paola de Donato
  • News
    • Events
    • Stories
  • What is FSHD
  • FSHD European Patient Survey
    • Lay Report
    • Supporters
  • FSHD European Trial Network
    • What is it about?
    • List of Genetic Testing Centres in Europe
    • Core Group of Experts
  • Research
    • Guidelines
    • Clinical trials
  • Governance
    • Policies
    • Financial Reports
    • Statutes
  • Links
Clinical trials News Recent research

A “patient friendly” summary by FSHD Society on the results of Fulcrums phase 2b study on Losmapimod

June 24, 2021 By Bine Haase
ReDUX4 trial result exceeds expectations

Post navigation

Previous PostPrevious Fulcrum announces results from ReDUX4 Trial with Losmapimod in FSHD
Next PostNext Annual General Assembly – 20.09.2021 (online)
Proudly powered by WordPress | Theme: Popularis